282 related articles for article (PubMed ID: 23336348)
1. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.
Wardlaw JM; von Kummer R; Carpenter T; Parsons M; Lindley RI; Cohen G; Murray V; Kobayashi A; Peeters A; Chappell F; Sandercock PA
Int J Stroke; 2015 Aug; 10(6):956-68. PubMed ID: 23336348
[TBL] [Abstract][Full Text] [Related]
2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
3. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial.
IST-3 collaborative group
Lancet Neurol; 2015 May; 14(5):485-96. PubMed ID: 25819484
[TBL] [Abstract][Full Text] [Related]
4. Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke.
Mair G; von Kummer R; Adami A; White PM; Adams ME; Yan B; Demchuk AM; Farrall AJ; Sellar RJ; Sakka E; Palmer J; Perry D; Lindley RI; Sandercock PA; Wardlaw JM;
Stroke; 2017 Feb; 48(2):353-360. PubMed ID: 28008093
[TBL] [Abstract][Full Text] [Related]
5. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
6. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
[TBL] [Abstract][Full Text] [Related]
7. Penumbra and re-canalization acute computed tomography in ischemic stroke evaluation: PRACTISE study protocol.
El-Tawil S; Wardlaw J; Ford I; Mair G; Robinson T; Kalra L; Muir KW
Int J Stroke; 2017 Aug; 12(6):671-678. PubMed ID: 28730951
[TBL] [Abstract][Full Text] [Related]
8. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
9. Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.
Lindley RI; Wardlaw JM; Whiteley WN; Cohen G; Blackwell L; Murray GD; Sandercock PA;
Stroke; 2015 Mar; 46(3):746-56. PubMed ID: 25613308
[TBL] [Abstract][Full Text] [Related]
10. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset.
Han MK; Kim SH; Ko SB; Paik NJ; Kwon OK; Lee YS; Oh CW; Kim JH; Park SH; Bae HJ
Neurocrit Care; 2008; 8(3):353-9. PubMed ID: 18340411
[TBL] [Abstract][Full Text] [Related]
11. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients.
Lee KY; Han SW; Kim SH; Nam HS; Ahn SW; Kim DJ; Seo SH; Kim DI; Heo JH
Stroke; 2007 Jan; 38(1):192-3. PubMed ID: 17110611
[TBL] [Abstract][Full Text] [Related]
12. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
[TBL] [Abstract][Full Text] [Related]
13. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
14. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
15. Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?
Ma L; Gao PY; Lin Y; Xue J; Wang XC; Wang YJ; Wang YL; Liao XL; Liu ML; Cui SM; Yu L; Tong SJ; Huang YL; Zhou YM
Neurol Res; 2009 May; 31(4):355-61. PubMed ID: 19508818
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
18. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
[TBL] [Abstract][Full Text] [Related]
19. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]